Top
»
Catalog
»
Peptides
»
010-66
中文版
|
My Account
|
CONTACT US
|
Peptides
Labeled Peptides
Peptide Libraries
Antibodies
Kits
Biomarker Array
Peptide Level Determination
Custom synthesis
Catalog Request
Customer Satisfaction Survey
Sample Preparation
FAQs
C7 / Calcitonin Receptor Antagonist
Catalog#
Standard size
Price
Order
010-66
100 µg
$180.00
Calcitonin Receptor-Stimulating Peptide (CRSP)
Normal Plasma Peptide/Protein Levels
AM2 receptors: C7
Catalog #
010-66
Family
Adrenomedullin / Calcitonin / CGRP
Standard Size
100 µg
Sequence
Thr - Val - Gln - Lys - Leu - Ala - His - Gln - Ile - Tyr - Gln - Phe - Thr - Asp - Lys - Gly - Arg - Gln - Asp - Ser - Val - Ala - Pro - Arg - Ser - Lys - Ile - Ser - Pro - Gln - Gly - Tyr - NH2
M.W
3647.11
Mass Spec Analysis
Exhibits correct M.W.
Solubility
Before reconstitution, please allow 25 to 45 minutes for the lyophilized peptide to return to room temperature. Briefly vortex the Eppendorf tube to concentrate all material at the bottom of the tube. Gently open the cap and reconstitute the peptide to the desired concentration by adding a sterile, aqueous solution to the tube. Invert the tube 5 times by hand to ensure a homogeneous solution.
Storage Condition
Store peptide in DRY form at 0-5°C. For best results and reproducibility, rehydrate peptide just before use. Do not attempt to weigh out smaller portions. Do not refreeze any unused portions.
Appearance
White powder
Content
The contents of this vial have been accurately determined to contain 100 µg of NET peptide.
HPLC Analysis
Purity ≥95%
Alphabet_C_
Search in :
CHOOSE CATEGORIES
• ALL CATEGORIES
• Peptides
• Labeled Peptides
Fluorescent
Radioactive
Biotin
• Peptide Libraries
• Antibodies
For Immunohistochemistry
Purified lgG
Labeled Antibodies
• Kits
RIA
ELISA/EIA
Western Blot
Dot Blot
• Biomarker Array
Cardiovascular
Obesity
Enter keyword
or choose a LETTER
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
0 items
US Dollar
Euro
Saturday 25 May, 2013
12976687 requests since Wednesday 05 April, 2006
Copyright © 2013
PHOENIX PHARMACEUTICALS, INC.